Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Oclaro, Inc. (Avanex-Bookham) -- Ignore unavailable to you. Want to Upgrade?

To: Shaw who wrote (1226)	12/4/2000 9:34:13 AM
From: Shaw	Read Replies (2) \| Respond to of 2293

The process invented by Dr. Cao enables the splitting of an optical signal into an extraordinarily high number of wavelengths, each capable of carrying a stream of data. Avanex has achieved 1,000 wavelengths in laboratory experiments, versus the current commercial maximum of 160. It would seem that the new MEM switches talked about in Barrons this weekend, can handle 1000 wavelengths. Wednesday November 15, 9:00 am Eastern Time Press Release SOURCE: Avanex Avanex Receives Patent for DWDM Technology FREMONT, Calif., Nov. 15 /PRNewswire/ -- Avanex Corporation (Nasdaq: AVNX - news), the global provider of photonic processors that enable next generation performance for optical communications networks, today announced that it has been issued a U.S. patent for its proprietary dense wavelength multiplexing (DWDM) process. Dr. Simon Cao, Chief Technology Officer for the company, is the inventor on the patent. Patent # 6,130,971 ``Fiber Optic Dense Wavelength Division Multiplexer with a Phase Differential Method of Wavelength Separation Utilizing a Polarization Beam Splitter and a Nonlinear Interferometer'' was issued to Avanex by the U.S. Patent and Trademark Office on Oct. 10. ``This is a highly significant patent for Avanex,'' company Chairman and CEO Walter Alessandrini said. ``The process invented by Dr. Simon Cao is a key enabling technology in Avanex's revolutionary photonic processing solutions. Award of the patent illustrates the unique nature of Avanex's approach, protects valuable intellectual property and establishes a formidable competitive barrier.'' Dr. Cao now holds five U.S. patents, with 33 more pending. The process invented by Dr. Cao enables the splitting of an optical signal into an extraordinarily high number of wavelengths, each capable of carrying a stream of data. Avanex has achieved 1,000 wavelengths in laboratory experiments, versus the current commercial maximum of 160. The patented DWDM process also can be easily modified to allow channels to be dropped or added, which addresses a major obstacle to a fully all-optical communications network. The patent application notes that the material required to manufacture and implement the process is readily available, making it cost-effective. Avanex's PowerMux(TM) Wavelength Channel Processor, which is based on the patented DWDM process, is shipping commercially. About Avanex Avanex designs, manufactures and markets photonic processors for the communications industry. Avanex's photonic processors offer communications service providers and optical systems manufacturers greater levels of performance and miniaturization, reduced complexity and increased cost- effectiveness as compared with current alternatives. Avanex was incorporated in 1997 and is headquartered in Fremont, Calif. In addition to a development and manufacturing facility in Fremont, the company also maintains The Photonics Center(TM) in Richardson, Texas. To learn more about Avanex, visit its web site at: www.avanex.com. Forward-looking Statements This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act. Actual results could differ materially from those projected in the forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, our inability to sufficiently anticipate market needs and develop products and product enhancements that achieve market acceptance. Avanex undertakes no obligation to publicly release the result of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Contact Information: Media Investor Relations Tony Florence Mark Weinswig Phone: 510-897-4162 Phone: 510-897-4344 Fax: 510-979-0198 Fax: 510-897-4345 e-mail: tony_florence@avanex.com e-mail: mark_weinswig@avanex.com SOURCE: Avanex Email this story - Most